Medications for Anemia In Chronic Kidney Disease

3 results

  • jesduvroq

    (daprodustat)
    GlaxoSmithKline LLC
    JESDUVROQ is indicated for treating anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months. It is not a substitute for red blood cell transfusions and is not indicated for non-dialysis CKD patients. No evidence of improved quality of life or fatigue.

  • retacrit

    (epoetin alfa-epbx)
    Pfizer Laboratories Div Pfizer Inc
    RETACRIT is indicated for treating anemia due to chronic kidney disease, zidovudine in HIV patients, chemotherapy in cancer patients, and to reduce RBC transfusions in high-risk surgical patients. It is not intended for patients treated with certain cancer therapies or those undergoing specific types of surgery.

  • vafseo

    (Vadadustat)
    Akebia Therapeutics, Inc.
    VAFSEO is indicated for anemia treatment in adults with chronic kidney disease (CKD) who have undergone dialysis for at least three months. It is not intended to improve quality of life or replace blood transfusions for immediate anemia correction, nor for CKD-related anemia in non-dialysis patients.